Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Net Income Loss of $24.02 million for the year ending 2025.
- IRONWOOD PHARMACEUTICALS INC showed an increase of +2,629.2% in Net Income Loss from 2024 to 2025.
- This data is from IRONWOOD PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), IRONWOOD PHARMACEUTICALS INC's Net Income Loss has grown by 116.8%.
- Historical annual values: Fiscal year 2025: $24.02 million | Fiscal year 2024: $880.0 thousand | Fiscal year 2023: -$1.00 billion | Fiscal year 2022: $175.07 million | Fiscal year 2021: $528.45 million | Fiscal year 2020: $106.18 million | Fiscal year 2019: $21.51 million | Fiscal year 2018: -$282.37 million | Fiscal year 2017: -$116.94 million | Fiscal year 2016: -$81.71 million | Fiscal year 2015: -$142.67 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: